Novo Undercuts Lilly With High-Dose Wegovy at $399 a Month

Novo Nordisk A/S will price its new high-dose Wegovy shot at $399 a month for cash-pay patients, undercutting the cost of most doses of rival Eli Lilly & Co.’s Zepbound.

High-dose Wegovy will be available starting on Tuesday, Novo said. The price is about 40% less than what Lilly charges cash-pay patients for the top three doses of Zepbound.